COVID-19 Response

AEI Clients in the COVID-19 fight: NIH, Amgen, Takeda

New public-private network to speed pandemic response.

The National Institutes of Health and the Foundation for the NIH have announced that they are assembling a government and industry partnership to identify, prioritize, and facilitate the most promising COVID-19 vaccine and drug candidates into clinical trials. To date, the group includes 16 leading biopharmaceutical companies, the CDC, the USFDA, the European Medicines Agency, and others.

Click to read full article

Post Date